Comments
Laurus Labs Ltd has launched the generic version of Lyrica, (pregabalin) capsules in all commercially available strengths in the US market along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company.
Rising had recently received the final approval from the US Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA).
Pregabalin Capsules are indicated for management of neuropathic pain associated with diabetic peripheralneuropathy, for the management of postherpetic neuralgia, for adjunctive therapy for the treatment of partial onset seizures in patients 4 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.